 | Campbell LM, Fennema-Notestine C, Barrett A, Sundermann E, Bondi MW, Saloner R, Clifford D, Ellis RJ, Franklin D, Gelman B, Grant I, Heaton RK, Marra C, Moore DJ, Morgello S, Letendre S, Moore RC. Prefrontal cortex, not medial temporal lobe, is associated with memory in middle-aged persons with HIV. International Neuropsychological Society annual meeting, 02-02-2022. | | Kamalyan L, Ham L, Umlauf A, Kohli M, Franklin DR, Letendre SL, Grant I, the CHARTER group. Effects of lifetime methamphetamine and alcohol use disorder and socioeconomic status on HIV-related quality of life. Research Society on Alcoholism, 06-20-2021. | | Ellis RJ, Moore DJ, Sundermann E, Heaton RK, Hulgan T, Samuels DC, Mehta SR, Letendre SL. Biomarkers of nucleic acid oxidation and neurodegeneration in CSF in PWH. Conference on Retroviruses and Opportunistic Infections, 03-09-2020. | | Anderson AM, Tang B, Vaida F, Okwuegbuna O, McClernon D, Deutsch R, Kundu S, Cherner M, Cookson D, Crescini M, Grant I, Ellis RJ, Letendre SL. CSF CXCL10 is associated with the presence of low-level CNS HIV during ART. Conference on Retroviruses and Opportunistic Infections, 03-09-2020. | | | Volpe K, Samuels D, Kallianpur A, Ellis R, Franklin D, Letendre S, Heaton R, Hulgan T. (2019). Mitochondrial DNA Haplogroup B is associated with Executive Function and Recall in Hispanic PLWH. CROI. | | | Campbell L, Fennema-Notestine C, Saloner R, Hussain M, Chen A, Franklin D, Umlauf A, Ellis R, Collier A, Marra C, Clifford D, Gelman B, Sacktor N, Morgello S, McCutchan J, Letendre S, Heaton R. Use of neuroimaging to inform optimal neurocognitive criteria for detecting HIV associated brain abnormalities. INS, 02-20-2019. | | Alakkas A, Ellis R, Watson W, Heaton R, Letendre S, Collier A, Marra C, Clifford D, Gelmen B, Sacktor N, Morgello S, Simpson D, McCutchan A, Kallianpur A, Gianella S, Vaida F, Marcotte T, Grant I, Fennema-Notestine C. Cerebral volumetric and metabolic abnormalities in HIVassociated
neurocognitive disorders
(HAND). Annual Meeting of the American Neurological Association, 10-15-2017. | | | Harpreet K, Hulgan T,Fennema-Notestine C,Smieszek S,Letendre S, Ellis R, Bush W, Soontornniyomkij V, Moore D, MasliahE,
SinsheimerJ, Barnholtz-Sloan J, Samuels D, Levine A, Kallianpur A. (2017). Common SNPs in the HFE(Hemochromatosis) gene are associated with neurocognitive impairment and aging-related neurodegenerative processes in HIV+ adults. 2017 HIV & Aging Conference. | | Iudicello J, Gongvatana A, Franklin D, Rosario D, Ellis R, Grant I, Heaton R, Letendre S. Profiles and predictors of HIV-associated neurocognitive impairment in the context of low and high blood-brain barrier (BBB) permeability. 45th Annual Meeting of the International Neuropsychological Societ, 02-01-2017. | | Ma Q, Iudicello J, Liu X, Franklin D, Grant I, Heaton R, Zhang F, Letendre S, for the CHARTER group and the China NeuroAIDS Team. CYP2B6 genotype affects global neurocognitive impairment in HIV-positive patients receiving Efavirenz: A CHARTER and China neuroAIDS study. Conference on Retroviruses and Opportunistic Infections, 02-22-2016. | | | Jia P. (2016). Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER Group Study. 23rd Annual Conference on Retroviruses and Opportunistic Infections. | | | McCutchan A, He J, Rey G, Bambhania K, Sanders C, Letendre S, Ellis R, Heaton R, Grant I, Sattler F. (2016). Impact of central obesity on HIV-associated cognitive impairment is limited by sex and race/ethnicity. 7th Workshop on HIV and Aging. | | Bush WS, S Smieszek, T Hulgan, M Cherner, RJ Ellis, SL Letendre, DC Samuels,
DR Franklin, I Grant, RK Heaton, and AR Kallianpur. Methamphetamine and genetically predicted expression of the cytoskeletal protein spectrin gene may interact to influence neurocognitive function in HIV+ adults. NIDA Genetics Consortium Meeting, 12-01-2016. | | Kallianpur A, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan J, Bush W, Heaton R, Samuels D, Franklin D, Clifford D, Collier A, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Grant I, Simpson D, Hulgan T, for the CHARTER Group. Novel CSF biomarker associations with HIV-associated neurocognitive disorder (HAND). Annual Conference on Retroviruses and Opportunistic Infections, 02-22-2016. | | | Evering T, St. Bernard L, Abolade J, Mohri H, Markowitz M. (2016). Relative frequency of drug resistance mutations on individual HIV-1 genomes in HAND. Annual Conference on Retroviruses and Opportunistic Infections. | | | Obermeit L, Beltran J, Casaletto K, Franklin D, Letendre S, Ellis R, Fennema-Notestine C, Vaida F, Collier C, Marra C, Clifford D, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Grant I, Heaton RK, and the CHARTER Group. Self-reported attribution of everyday dysfunction: Defining functional dependence in HIV. Forty-Fourth Annual Meeting of the International Neuropsychological Society, 02-03-2016. | | | Heaton RK, Franklin D, Letendre SL, Ellis RJ, Fennema-Notestine C, Vaida F, Smith D, Collier A, Marra C, Clifford D, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Grant I, for the CHARTER Group. (2015). Aging amplifies HIV neurocognitive impairment. HIV & Aging Conference. | | | Edén A. (2015). CNS immunoactivation and neuronal damage in patients with progressive neurocognitive impairment. 2015 Annual Conference on Retroviruses and Opportunistic Infections. | | | Anderson AM, Fennema-Notestine C, Umlauf A, Clifford DB, Marra CM, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Letendre S, for the CHARTER Group. (2015). CSF biomarkers correlate with magnetic resonance spectroscopy metabolites during HIV disease. Conference on Retroviruses and Opportunistic Infections. | | Kallianpur A, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan J, Bush W, Heaton R, Samuels D, Franklin D, Clifford D, Collier A, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Grant I, Simpson D, and Hulgan T, for the CHARTER Group. CSF biomarkers of iron transport and angiogenesis are associated with HAND. 13th International Symposium on NeuroVirology, 06-02-2015. | | Oliveira M, Murrell B, Perez-Santiago J, Vargas M, Ellis R, Letendre S, Grant I, Smith D, Woods S, Gianella S. HIV DNA and neurocognitive impairment in older subjects on suppressive ART. 2015 Annual Conference on Retroviruses and Opportunistic Infections, 02-23-2015. | | Thornton-Wells T, Fennema-Notestine C, Hulgan T, Letendre S, Ellis R, Kallianpur A, for the CHARTER Group. Iron-Regulatory genes are associated with neuroimaging traits in HIV infection. 2015 Conference on Retroviruses and Opportunistic Infections, 02-23-2015. | | | Fazeli P, Moore DJ, Franklin DR, Heaton RK, Marra C, Gelman B, McCutchan JA, Grant I, Letendre S, for the CHARTER Group. (2015). Lower CSF Amyloid-β levels are associated with worse neurocognitive functioning in HIV-infected adults with a family history of dementia. 2015 Annual Conference on Retroviruses and Opportunistic Infections. | | | Hulgan T, Samuels D, Ellis R, Bush W, Letendre S, Franklin D, Grant I, Kallianpur A. (2015). Mitochondrial DNA haplogroups and CSF neuroinflammation in the CHARTER cohort. 2015 Annual Conference on Retroviruses and Opportunistic Infections. | | Pérez-Santiago J, De Oliveira MF, Murrell B, Var S, Day T, Woods S, Ellis R, Gianella S, Mehta S. Mitochondrial DNA, neurologic and systemic inflammation, and immune dysregulation. 2015 Annual Conference on Retroviruses and Opportunistic Infections, 02-23-2015. | | | Marquine M. (2015). Neurocognitive decline in HIV-infected Hispanics: Rates and predictors. 43rd Annual Meeting of the Neuropsychological Society. | | Moore D, Fazeli P, Casaletto K, Letendre S, Scott J, Woods S, Jeste D, Grant I, and the HNRP Group. Neuropsychological functioning is associated with multitasking in older HIV+ adults. 43rd Annual Meeting of the International Neuropsychological Society, 02-04-2015. | | | Marquine M, Moore DJ, Byrd D, Rivera-Mindt M, Cherner M, Jeste D, Ellis R, Letendre SL, Heaton RK. (2015). Older HIV-infected Hispanics are at increased risk for neurocognitive impairment. HIV & Aging Conference. | | | Brouillette MJ, Yuen T, Scott SC, Fellows LK, Heaton R, Letendre S, Ellis RJ, Mayo N. (2015). Predictors of neurocognitive decline among aviremic individuals in the CHARTER cohort. Conference on Retroviruses and Opportunistic Infections. | | Yek C, Smith DM, Wagner GA, Morgello S, Letendre S, Grant I, Kosakovsky Pond SL, Gianella S, the CHARTER Study Group. Suppressive ART is key to reduce neurocognitive impairment in aging HIV+ individuals. 2015 Annual Conference on Retroviruses and Opportunistic Infections, 02-23-2015. | | Singh K, Deng Q, Fennema-Notestine C, Vaida F, Ellis RJ, Letendre SL, Franklin D, Rosario D, Heaton RD, Grant I, and CHARTER Group. Synergistic effects of MBL2/APP polymorphisms on neurocognitive impairment in CHARTER. 2015 Annual Conference on Retroviruses and Opportunistic Infections, 02-23-2015. | | Sattler F, He J, Letendre S, Wilson C, Fitzsimmons C, Heaton R, Ellis R, Franklin D, Grant I, McCutchan A, for the CHARTER Group. Abdominal obesity, inflammation, immune activation and neurocognitive impairment in HIV. 21st Conference on Retroviruses and Opportunistic Infections, 03-03-2014. | | Kallianpur A, Wang Q, Jia P, McArthur JC, Morgello S, Collier AC, Gelman BB, Clifford DB, McCutchan JA, Grant I, and the CHARTER Study Group. Blood Cell Indices and Neurocognitive Impairment in the HAART Era: a CHARTER Study. 21st Conference on Retroviruses and Opportunistic Infections, 03-03-2014. | | Pérez-Valero I, Letendre S, Heaton R, Ellis R, MCCutchan A, Simpson D, Deutsch R, Grant I, and the CHARTER Group. CSF biomarker profile in HIV patients with and without CSF viral escape. 21st Conference on Retroviruses and Opportunistic Infections, 03-03-2014. | | Anderson AM, Fennema-Notestine C, Umlauf A, Clifford D, Marra C, Gelman B, McArthur J, McCutchan A, Morgello S, and Letendre S, for the CHARTER group. CSF biomarkers correlate with magnetic resonance spectroscopy metabolites during HIV disease. 21st Conference on Retroviruses and Opportunistic Infections, 03-03-2014. | | Wagner GA, Chaillon A, Franklin DR, Caballero G, Kosakovsky Pond SL, Heaton RK, Richman DD, Smith D, and the CHARTER Group. HIV-associated neurocognitive disorder is associated with HIV-1 dual infection. 21st Conference on Retroviruses and Opportunistic Infections, 03-03-2014. | | | Marquine MJ, Moore DJ, Cherner M, Ellis R, Deutsch R, Franklin D, Letendre S, Collier A Marra C, Clifford D, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Heaton RK, Grant I and the CHARTER Group. (2014). HIV-infected Hispanics are at increased risk for neurocognitive impairment. UCSD 9th Annual Lewis L. Judd Young Investigators Research Symposium. | | Pérez-Valero I, Heaton R, Franklin D, Letendre S, Deutsch R, Gelman B, Simpson D, Collier A, Grant I, and the CHARTER Group. HIV-replication control rates needed to prevent neurocognitive performance (NP) decline. 21st Conference on Retroviruses and Opportunistic Infections, 03-03-2014. | | | Gelman BB, Ahuja S, Ellis R, Letendre S, Marra C, McArthur J, Morgello S, Clifford D, Grant I, Vaida F. (2014). HLA gene loci associated with HIV load in csf and blood plasma in the CHARTER cohort. 21st Conference on Retroviruses and Opportunistic Infections. | | | Gelmen BB, Ahuja SK, Ellis RJ, Letendre SL, Marra CM, McArthur JC, Morgello SM, Clifford DB, Grant I, Vaida F, for the CHARTER Group. (2014). HLA gene loci associated with HIV viral load in CSF and blood plasma in the CHARTER cohort. Conference on Retroviruses and Opportunistic Infections. | | Singh K, Vaida F, Fennema-Notestine C, Ellis R, Letendre S, Franklin D, Deng Q, Rosario D, Corkran S, Heaton R, Grant I, and CHARTER Group. MBL2 promoter polymorphism rs7096206 predicts brain metabolite anomalies in HIV-infected adults. 21st Conference on Retroviruses and Opportunistic Infections, 03-03-2014. | | Hulgan T, Samuels D, Bush W, Ellis R, Letendre S, Straub P, Murdock D, Franklin D, Grant I, Kallianpur A, for the CHARTER Group. Mitochondrial DNA haplogroups and neurocognitive impairment in the CHARTER Cohort. 21st Conference on Retroviruses and Opportunistic Infections, 03-03-2014. | | | Pérez-Santiago J, Mehta SR, Gianella S, Schrier R, Cherner M, Var SR, Day TRC, Ramirez-Gaona M, Smith DM and Letendre S. (2014). Mitochondrial DNA is associated with inflammation and neurocognitive deficits in HIV infection. 21st Conference on Retroviruses and Opportunistic Infections. | | Heaton R, Franklin D, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine M, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Grant I, for the CHARTER Group. Neurocognitive change in the era of HIV combination antiretroviral therapy: A CHARTER Study. 20th International AIDS Conference, 07-20-2014. | | | Edén A. Normal cerebrospinal fluid neurofilament light protein, but increased intrathecal immunoactivation in virally-suppressed HIV-infected patients with mild neurocognitive impairment. 21st Conference on Retroviruses and Opportunistic Infections, 03-03-2014. | | Hammond ER, Crum RM, Treisman GJ, Mehta SH, Clifford DB, Ellis RJ, Gelman BB, Grant I, Letendre SL, Marra CM, Morgello S, Simpson DM, McArthur JC, for the CHARTER Group. Persistent csf, but not plasma HIV RNA is associated with Increased risk of new-onset depression. 21st Conference on Retroviruses and Opportunistic Infections, 03-03-2014. | | Hammond ER, Crum RM, Treisman GJ, Mehta SH, Clifford DB, Ellis RJ, Gelman BB, Grant I, Letendre SL, Marra CM, Morgello S, Simpson DM, McArthur JC, for the CHARTER Group. The Cerebrospinal Fluid HIV Risk Score for assessing central nervous system HIV activity. 21st Conference on Retroviruses and Opportunistic Infections, 03-03-2014. | | | Singh K, Vaida F, Fennema-Notestine C, Ellis R, Letendre S, Franklin D, Deng Q, Rosario D, Heaton R, Grant I, and the CHARTER Group. (2013). A loss of function Polymorphism in complement Factor H predicts HIV-1 related neurocognitive impairment and neuroimaging abnormalities. 20th Conference on Retroviruses and Opportunistic Infections. | | Keltner JR, Connolly CG, Vaida F, Franklin DR, FitzSimons C, Corkran S, Grant I, Atkinson JH, Ellis RJ. HIV-associated distal neuropathic pain is associated with smaller ventral posterior cingulate cortex. 32nd Annual Scientific Meeting of the American Pain Society, 05-08-2013. | | | Ellis R, Iudicello J, Marquine M, Ghias A, Heaton R, Kao Y, Deutsch R, McCutchan JA. (2013). Impact of metabolic syndrome and vascular risk factors on age-related neurocognitive decline in HIV. 4th International Workshop on HIV and Aging. | | Perez-Valero I, Letendre S, Deutsch R, Heaton R, Clifford DB, McArthur J, Morgello S, Gelman B, Collier A, Grant I, the CHARTER Group, and the HNRP Group. Incidence, risk factors and neurocognitive impact of CSF viral escape: Longitudinal analysis of the CHARTER & HNRP Cohorts. 20th Conference on Retroviruses and Opportunistic Infections, 03-05-2013. | | Letendre S, Vaida F, Wong S, Croteau D, FitzSimons C, Grant I, Ellis R. Long-term efavirenz use is associated with worse neurocognitive functioning. 20th Conference on Retroviruses and Opportunistic Infections, 03-05-2013. | | Letendre S, McClernon D, Deutsch R, Cherner M, Cookson, Crescini M, Grant I, Ellis R. Low-level HIV RNA declines over time in csf but not in plasma. 20th Conference on Retroviruses and Opportunistic Infections, 03-05-2013. | | Fennema-Notestine C, Taylor MJ, Notestine RJ, Wolfson T, Gamst AC,
Archibald SL, Theilmann RJ, Heaton RK, Marra C, Grant I, for the CHARTER Group. Neuroimaging correlates of prior immunosuppression and cognitive status in HIV. 20th Conference on Retroviruses and Opportunistic Infections, 03-05-2013. | | | Heaton RK, Letendre S, Collier A, Clifford D, Gellman B, Marra C, Morgello S, McArthur J, McCutchan A, Simpson D, Franklin D, Grant I, for the CHARTER Group. (2013). Overview of HIV Associated Neurocognitive Disorders (HAND): Findings from the Six-Site CNS HIV Anti-Retroviral Effects Research (CHARTER). 2013 Mid-Year Meeting International Neuropsychological Society. | | | McCutchan JA, Marquie-Beck J, Fitzsimons C, Letendre S, Ellis R, Heaton R, Wolfson T, Marra C, Ances B, Grant I, and the CHARTER Group. (2013). Role of central obesity, diabetes, and metabolic variables in HIV-associated neurocognitive disorders. 20th Conference on Retroviruses and Opportunistic Infections. | | Franklin D, Heaton R, Woods S, Letrendre S, Collier A, Clifford D, Gelman B, McArthur J, Simpson J, Grant I. Veterans Aging Cohort Study (VACS) index score are associated with cognition and HAND symptoms: A CHARTER Study. 20th Conference on Retroviruses and Opportunistic Infections, 03-05-2013. | | | Ellis R, Letendre SL, Rosario D, Gelman B, Clifford D, Simpson D, McArthur J, Marra C, McCutchan JA, Grant I, for the CHARTER Group. (2012). A common polymorphism in the COMT gene confers an increased risk of neuropathic pain in HIV sensory neuropathy. 2012 American Academy of Neurology. | | | Letendre S, Marcotte T, Deutsch R, Franklin D, Rosario D, Alexander T, Haughey N, Pardo C,
Fox H, Grant I. (2012). A concise panel of biomarkers diagnoses and predicts neurocognitive (NC) status in HIV-Infected individuals. 19th Conference on Retroviruses and Opportunistic Infections. | | Haughey N, Mielke M, Bandaru V, Sacktor N, Grant I,
Letendre S, Fox H, Chang L, Wozna V, Pardo C, McArthur J. A lipidomic analysis of CSF from HIV-infected subjects identifies metabolites that predict change in cognitive performance. 19th Conference on Retroviruses and Opportunistic Infections, 03-05-2012. | | Heaton R, Franklin D, Letendre S, Ellis R,
Fennema-Notestine C, Vaida F, Smith D, Collier A,
Marra C, Clifford D, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan A, Grant I, for the CHARTER Group. (2012). Aging amplifies HIV neurocognitive impairment: The effects may be related to vascular and metabolic factors. Journal of NeuroVirology, 18(Suppl 1), S46. | | | Heaton R, Franklin D, Woods S, Marra C, Clifford D,
Gelman B, McArthur J, Morgello S, McCutchan A, and Grant I. (2012). Asymptomatic mild HIV-associated neurocognitive disorder increases risk for future symptomatic decline: A CHARTER longitudinal study. 19th Conference on Retroviruses and Opportunistic Infections. | | Blackstone K, Moore DJ, Franklin DR, Woods SP, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Rivera-Mindt M, Ellis RJ, Atkinson JH, Grant I, Heaton RK, for the CHARTER Group. Deficit scores versus clinical ratings: Defining neurocognitive impairment in HIV. 40th Annual Meeting of the International Neuropsychological Society, 02-15-2012. | | Ferrara M, Umlauf A, FitzSimons C, Meyer J, Duarte N, Atkinson JH, Grant I, Ellis R, for the CHARTER Group. Effect of second generation antipsychotics on metabolic variables in HIV-infected adults on long term antiretroviral therapy. International AIDS Conference, Washington, DC, 07-22-2012. | | | Burdo T, Weiffenbach A, Woods S, Letendre L, Ellis R, Williams K. (2012). Elevated sCD163 in NP impaired HIV+ individuals despite virally suppressive ART. 19th Conference on Retroviruses and Opportunistic Infectons. | | Choi JY, Heaton R, Grant I, Marcotte T, Ellis R, Letendre R, Marra C, Clifford D, Richman D, Smith D, and the CHARTER Group. Genetic features of cerebrospinal fluid-derived subtype B HIV-1tat. 19th Conference on Retroviruses and Opportunistic Infections, 03-05-2012. | | Letendre S, Bharti A, Perez Valero I, Landay A, Hanson, Franklin D, Woods S, Heaton R, Grant I, Lurain N, for the CHARTER Group. Higher
ctomegalovirus
(CMV)
antibody
concentrations
are
associated
with
older
age,
lower
nadir
CD4+
cell
counts,
and
worse
global
neurocognitive
(NC)
functioning
in
people
with
HIV
disease. 19th Conference on Retroviruses and Opportunistic Infections, 03-05-2012. | | Blackstone K, Moore DJ, Woods SP, Morgan EE, Franklin DR, Ellis RJ, Letendre SL, Grant I, Heaton RK, and the CHARTER Group. How "asymptomatic" is HIV-associated asymptomatic neurocognitive impairment? 19th Conference on Retroviruses and Opportunistic Infections, 03-05-2012. | | Letendre SL, Vaida F, Ellis R, Clifford D, Gelman B, Marra C, McArthur J, McCutchan A, Simpson D, Grant I, and the CHARTER Group. Longitudinal correlates of HIV RNA levels in 2,207 CSF specimens. 19th Conference on Retroviruses and Opportunistic Infections, 03-05-2012. | | Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Alexander T, Morgan EE, Woods S, Collier A,
Clifford D, Gelman B, McCutchan A, McArthur J, Morgello S, Grant I, and the CHARTER
Group. Norms
and
alternative
cutpoints
improve
sensitivity/specificity
tradeoff
for
the
HIV
Dementia
Scale:
The
CHARTER
study. 40th Annual Meeting of the International Neuropsychological Society, 02-15-2012. | | Croteau D, Letendre S, Best B, Clifford D, Gelman B, Marra C, McArthur J, McCutchan JA, Simpson D, Grant I. Older age is associated with higher antiretroviral
concentrations in cerebrospinal fluid in HIV-infected individuals. 19th Conference on Retroviruses and Opportunistic Infections, 03-05-2012. | | Heaton R, Deutsch R, Franklin D, Woods S, Collier A,
Clifford D, Gelman B, McArthur J, Simpson D, Grant I, for the CHARTER Group. Prevalence and predictors of neurocognitive decline over 18 to 42 months: A CHARTER
longitudinal study. 19th Conference on Retroviruses and Opportunistic Infections, 03-05-2012. | | Pérez-Valero I, Letendre S, Ellis R, Deutsch R, Franklin D, Clifford DB, Heaton R, McCutchan J, McArthur J, Morgello S, Gelman B, Collier A, Grant I, and the CHARTER & HNRP Groups. Prevalence and risk factors for HIV CSF viral escape: Results from the CHARTER and HNRP cohorts. 11th International Congress on Drug Therapy, Glasgow, Scotland, 11-11-2012. | | McCutchan JA, Marquie-Beck J, FitzSimons C, Letendre S, Ellis RJ, Heaton R, Wolfson T, Marra C, Ances B, Grant I, for the CHARTER Group. Role of central obesity, diabetes, and metabolic variables in HIV-associated neurocognitive disorder. 19th Conference on Retroviruses and Opportunistic Infections, 03-05-2012. | | Ellis R, Gelman B, Letendre S, Clifford D, Marra C, McArthur J, McCutchan J,Simpson D, Grant I, and the CHARTER Group. Soluble CD14 in cerebrospinal fluid in HIV sensory neuropathy. 19th Conference on Retroviruses and Opportunistic Infections, 03-05-2012. | | Perez-Valero I, Heaton R, Letendre S, McCutchan J, Morgello S, Gelmen B, Collier A, Grant I, and the CHARTER Group. Validation of the EACS guidelines 2011 algorithm for detecting HAND in the CHARTER cohort. 19th Conference on Retroviruses and Opportunistic Infections, 03-05-2012. | | Cushman C, Gamst A, Yamada L, Ellis R, Alexander T, Grant I. Web-based collection of antiretroviral medication histories. 11th International Symposium on NeuroVirology, 05-29-2012. | | | Clifford D, Morgan E, Vaida F, Heaton R, Goate A, Bloss C, Marra C, Ances B, Collier A, Gelman B, McArthur J, Morgello S, Letendre S, Grant I, for the CHARTER Study. (2011). APOE Genotype is not related to Neurocognitive Function in HIV: CHARTER Analysis. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 17-20, Rome, Italy. | | | Keltner JR, Vaida F, Ellis R, Moeller-Bertram T, Franklin D, FitzSimons C, Corkran S, Duarte N, Robinson-Papp J, Dworkin R, Clifford D, Gelman B, Simpson D, McArthur J, Mccuthan A, Collier A, Marra C, Morgello S, Atkinson J, Grant I, for the CHARTER Group. (2011). Depression is associated with more functional impairment than distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. The American Pain Society’s 30th Annual Scientific Meeting May 19-21, Austin, Texas. | | | Blackstone K, Moore DJ, Franklin DR, Woods SP, Clifford DB, Collier AC, Marra CM, Gelman BB, McARthur JC, Morgello S, Simpson DM, Rivera-Mindt M, Deutsch R, Ellis RJ, Atkinson JH, Hetaon RK, Grant I. (2011). Diagnosing symptomatic HIV-associated cognitive disorders: Self-report versus performance-based assessment everyday functioning. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 17-20, Rome, Italy. | | Holzinger E, Hulgan T, Ellis R, Samuels D, Clifford D, Collier A, Gelman B, Morgello S, Letendre S, Grant I, and the CHARTER Group. Full sequence mtDNA variation and HIV-SN in the CHARTER cohort. 18th Conference on Retroviruses and Opportunistic Infections, Boston, Mass, 02-28-2011. | | | Hightower G, Wong J, Letendre S, Umlauf A, Ellis R, Ignacio C, Heaton R, Grant I, Richman D, Smith D, and the CHARTER Group. (2011). Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. 18th Conference on Retroviruses and Opportunistic Infections, Boston, Mass. | | Heaton R, Franklin D, Ellis RJ, Letendre S, LeBlanc S, Woods SP, Clifford D, Rivera-Mindt M, Taylor M, Marcotte T, Atkinson JH, Collier A, Marra CM, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Grant I, for the CHARTER and HNRC Groups. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy. Neuropsychological Society 39th Annual Meeting, Boston, Mass, 02-02-2011. | | Kallianpur A, Ellis R, Marra C, Simpson D, McArthur J, Clifford D, Gelman B, McCutchan A, Letendre S, Grant I, and the CHARTER Group. Impact of genetic variation in iron transport pathways on neuropathy morbidity during ART: Results from the CHARTER Genome-wide Study. 18th Conference on Retroviruses and Opportunistic Infections, Boston, Mass, 02-28-2011. | | | Fennema-Notestine C, Letendre SL, Archibald SL, Jernigan TL, Ellis RJ, Taylor MJ, Theilmann RJ, Julaton ML, Croteau D, Wolfson T,
Heaton RK, Gamst AC, Franklin DR, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, for the CHARTER Group. Increasing CD4 levels are associated with more white matter abnormalities and increased gray matter over time in HIV: The CHARTER Study. Fourth International Meeting on HIV Infection and the Central Nervous System, Frascati (Rome), Italy, 07-15-2011. | | Letendre S, Croteau D, Ellis R, Clifford D, Gelman B, Marra C, McArthur J, McCutchan A, Simpson D, Grant I, and the CHARTER Group. Lower CSAR are associated with global neurocognitive impairment in antiretroviral-treated people with HIV. 18th Conference on Retroviruses and Opportunistic Infections, Boston, Mass, 02-28-2011. | | Marra C, Deutsch R, Collier A, Morgello S, Letendre S, Clifford D, Gelman B, McArthur J, McCutchan A, Grant I, and the CHARTER Group. Neurocognitive impairment in HIV-infected patients with past syphilis. 18th Conference on Retroviruses and Opportunistic Infections, Boston, Mass, 02-28-2011. | | Archibald S, Fennema-Notestine C, McCutchan JA, FitzSimons C, Ances B, Wolfson T, Jernigan T, Ellis RJ, Collier A, McArthur J, Morgello S, Simpson D, Marra C, Gelman B, Clifford D, Grant I, for the CHARTER Group. Neuroimaging correlates of metabolic variables in HIV: The CHARTER Study. Fourth International Meeting on HIV Infection and the Central Nervous System, Frascati (Rome), Italy, 07-15-2011. | | Patton D, Woods SP, Franklin D, Heaton RK, Collier A, Marra C, Clifford D, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Grant I, for the CHARTER Group. Relationship of medication management test-revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV. International Neuropsychological Society 39th Annual Meeting, Boston, Mass, 02-02-2011. | | Best B, Letendre S, Croteau D, Capparelli E, Clifford D, Gelman B, Marra C, McArthur J, Simpson D, Grant I, and the CHARTER Group. Therapeutic DRV and ETR concentrations in CSF. 18th Conference on Retroviruses and Opportunistic Infections, Boston, Mass, 02-28-2011. | | | Ellis RJ, FitzSimons C, McArthur JC, Polydefkis M, Clifford D, Simpson D, Gelman BB, Morgello S, Collier A, Marra C, McCutchan JA, Grant I. (2011). Virologic suppression enhances epidermal nerve fiber recovery in HIV infection. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 17-20, Rome, Italy. | | Moore DJ, Letendre SL, Deutsch R, Little S, Smith D, Morris S, Franklin DR, Gouaux B, LeBlanc S, Rosario D, Heaton RK, Ellis R, Atkinson JH, Grant I, for the CHARTER Group. Acute and early HIV-infected persons evidence learning impairments. International Neuropsychological Society 38th Annual Meeting, Acapulco, MX, 02-03-2010. | | | Letendre SL, FitzSimons C, Ellis RJ, Clifford D, Collier AC, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Simpson D, Vaida F, Heaton R, Grant I, and the CHARTER Group. (2010). Correlates of CSF Viral Loads in 1,221 volunteers of the CHARTER cohort. 17th Conference on Retroviruses and Opportunistic Infections. | | Letendre SL, Ellis RJ, Deutsch R, Clifford D, Collier AC, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Simpson D, Heaton R, Grant I, and the CHARTER Group. Correlates of time-to-loss-of-viral-response in CSF and plasma in the CHARTER Cohort. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 02-16-2010. | | Lin K, Taylor MJ, Heaton RK, Franklin D, Jernigan TL, Fennema-Notestine C, McCutchan A, Atkinson JH, McArthur J, Morgello Simpson D, Collier A, Marra C, Gelman B, Clifford D, Grant I, for the CHARTER Group. Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV+ individuals. 38th Annual International Neuropsychological Meeting, Acapulco, MX, 02-03-2010. | | Moore DJ, Moseley S, McCutchan JA, Marquie-Beck JA, Frankiln DR, Vaida F, Achim C, Grant I, the CHARTER Group, the HNRC Group. Family history of dementia may increase risk for neuropsychological impairment among HIV infected persons. esented at the American Academy of Clinical Neuropsychology, 2010. | | Ellis RJ, Heaton RK, Letendre SL, Badiee J, Munoz-Moreno JA, Vaida F, Clifford DB, Gelman BB, Simpson DM, Grant I, for the CHARTER Group. Higher CD4 nadir is associated with reduced rates of HIV-associated neurocognitive disorders in the CHARTER Study: Potential implications for early treatment initiation. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 02-16-2010. | | Moore DJ, Letendre SL, Deutsch R, Little S, Smith D, Franklin DR, Rosario D, Heaton RK, Grant I, for the CHARTER Group. HIV-associated neurocognitive disorder (HAND) in acute and early HIV infection. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 02-16-2010. | | Heaton R, Franklin D, Ellis R, Letendre S, LeBlanc S, Woods S, Clifford D,Rivera Mindt M, Taylor M, Marcotte T, Atkinson JH, Collier A, Marra C, Gelman B, McArthur J, Morgello S,Simpson D, McCutchan JA, Grant I
for the CHARTER and HNRC Groups. Increased rate of HIV neurocognitive impairment (NCI) among non-AIDS cases in the post-CART versus pre-CART era. III International AIDS Conference, Vienna, Austria, 07-18-2010. | | Fennema-Notestine C, Archibald SL, Notestine RJ, TaylorMJ,
Theilmann RJ, Julaton M, Letendre SL, Ellis RJ, Heaton RK,
Gamst AC, Franklin, Jr. DR, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, Jernigan TL, for the CHARTER Group. Increasing CD4 levels are associated with more white matter abnormalities and increased gray matter over time in HIV: The CHARTER Study. Society for Neuroscience Annual Meeting, San Diego, CA, 11-13-2010. | | Croteau D, Best B, Letendre S, Rossi S, Ellis RJ, Clifford D, Collier A, Gelman B, Marra C, McArthur J, McCutchan JA, Morgello S, Simpson D, Way L, Capparelli E, Grant I. Lower than expected Maraviroc concentrations in cerebrospinal fluid still exceed the 50% inhibitory concentration for wild-type CCR5-tropic HIV-1. International Society for NeuroVirology, Milan, Italy, 10-12-2010. | | | Ellis R, Badiee J, Letendre S, Vaida F, Franklin D, Heaton R, Clifford D, Collier A, Marra C, Gelman B, McArthur J, Morgello S, Simpson D, McCutchan JA, Grant I, for the CHARTER Group. (2010). Nadir CD4 is a predictor of HIV neurocognitive impairment (NCI) in the era of combination antiretroviral therapy: results from the CHARTER Study. XVIII International AIDS Conference, July 18-23, Vienna, Austria. | | Al-Lozi M, Ellis R, Vaida F, FitzSimons C, McCutchan JA, McArthur J, Morgello S, Simpson D, Collier A, Marra C, Gelman B, Clifford D, Letendre S, Grant I, for the CHARTER Group. Peripheral nerve function in HIV-infection: electrophysiological and quantitative sensory test results in the CHARTER Study. American Academy of Neurology, Toronto, Canada, 04-10-2010. | | Malvar J, Ellis R, Vaida F, Robinson-Papp J, Atkinson JH, Fan J, FitzSimons C, Collier A, McCutchan JA, McArthur J, Morgello S, Simpson D, Marra C, Gelman B, Clifford D, Letendre S, Grant I, for the CHARTER Group. Predictors of incident distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. International Society for NeuroVirology, Milan, Italy, 10-12-2010. | | Badiee J, Moore DJ, Vaida F, Franklin D, Gouaux B, McCutchan JA, Atkinson JH, Heaton RK, McArthur J, Morgello S, Simpson D, Collier A, Marra C, Gelman B, Clifford D, Grant I, for the CHARTER Group. Suicidality and neuropsychological impairment in HIV-infected persons. International Neuropsychological 38th Annual Meeting, Acapulco, MX, 02-03-2010. | | Moore D, Arce M, Moseley S, McCutchan JA, Letendre SL, Vaida F, Achim CL, McArthur J, Morgello S, Simpson D, Gelman B, Collier A, Marra C, Clifford D, Grant I, the CHARTER Group, and the HNRC Group. The influence of family history of dementia on neuropsychological functioning among HIV infected persons across the lifespan. 1st International Conference on HIV and Aging, 2010. | | Bharti AR, Letendre S, Wolfson T, Clifford D, Collier A, Gelman B, McArthur J, McCutchan A, Morgello S, Grant I. Clinical risk factors identify seronegative HCV co-infection in substantial minority of CHARTER participants. International Society for Neurovirology, 10-2009. | | Best B, Letendre S, Capparelli E, Ellis R, Rossi S, Koopmans P, Grant I, and the CHARTER Group. Efavirenz and emtricitabine concentrations consistently exceed wild-type IC50 in cerebrospinal fluid: CHARTER findings. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 02-08-2009. | | | Heaton R, Franklin D, Clifford D, Woods SP, Rivera-Mindt M, Vigil O, Taylor M, Marcotte T, Atkinson JH, Grant I. (2009). HIV-associated Neurocognitive Impairment (NCI) Remains Prevalent in the Era of Combination Antiretroviral Therapy (CART): The CHARTER Study. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada. | | Ances B, Rosario D, Vaida F, Marquie-Beck J, Ellis R, Simpson D, Clifford D, McArthur J, McCutchan J, Grant I. Metabolic syndrome components as risk factors for distal sensory polyneuropathy: CHARTER findings. 16th Conference on Retroviruses and Opportunistic Infections, 02-08-2009. | | McCutchan JA, Marquie-Beck J, Letendre S, Heaton R, Wolfson T, Rosario D, Alexander T, Marra C, Ances B, Grant I. Metabolic syndrome, diabetes, and cognitive impairment in the era of combination antiretroviral therapy. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 02-08-2009. | | Ellis RJ, Rosario D, Clifford D, McArthur J, Simpson D, Alexander TJ, Marra C, Gelman BB, Atkinson JH, Dworkin RH, Vaida F, Grant I. Neuropathic pain contributes to an excess of unemployment and disability in HIV infection: the CHARTER Study. International Society for Neurovirology, 10-2009. | | Heaton RK, Franklin DR, Clifford D, Woods SP, Mindt MR, Vigil OR, Taylor MJ, Marcotte TD, Atkinson JH, Grant I, and the CHARTER Group. Persistence and progression of HIV-associated neurocognitive impairment (NCI) in the era of combination antiretroviral therapy (CART) and the role of comorbidities: The CHARTER Study. International Society for Neurovirology, 10-2009. | | Letendre S, McClernon D, Ellis RJ, Munoz-Moreno J, Way L, Clifford D, Collier A, Gelman B, Marra C, McArthur J, McCutchan A, Morgello S, Simpson D, Franklin D, Heaton R, Grant I, and the CHARTER Group. Persistent HIV in the central nervous system (CNS) during treatment is associated with worse antiretroviral therapy (ART) penetration and cognitive impairment. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 02-08-2009. | | Munoz-Moreno J, Letendre S, McClernon D, Ellis RJ, LeBlanc S, Rosario D, Clifford D, Collier A, Gelman B, Marra C, McArthur J, McCutchan A, Morgello S, Simpson D, Franklin D, Heaton RK, Grant I, and the CHARTER Group. Persistent HIV in the central nervous system during treatment is associated with worse antiretroviral therapy penetration and cognitive impairment. International Society for Neurovirology, 10-2009. | | Ellis R, Rosario D, Clifford D, McArthur J, Simpson D, Alexander T, Gelman B, Grant I. Persisting High Prevalence of HIV Distal Sensory Peripheral Neuropathy (DSPN) in the Era of Combination Antiretroviral Therapy (CART): Correlates in the CHARTER Study. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 02-08-2009. | | | Ellis R, Rosario D, Clifford D, McArthur JC, Simpson D, Alexander T, Gelman B, Collier A, Marra C, Ances B, Grant I. (2009). Prevalence, correlates and impact of neuropathic pain in HIV infection: the CHARTER Study. American Academy of Neurology. | | Ellis RJ, Rosario D, Clifford D, McArthur J, Simpson D, Alexander T, Marra C, Morgello S, Gelman BB, Dworkin RH, Vaida F, Grant I. Risk factors for incident neuropathic pain in HIV infection: the CHARTER study. International Society for Neurovirology, 10-2009. | | Byrd D, Morgello S, Franklin D, Heaton R, Grant I. Substance use and HIV infection: Neurocognitive impact in the CHARTER cohort. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 02-08-2009. | | | Clifford DB, Kauwe JSK, Teshome M, Shah AR, Spinner ML, Morris JC, Holtzman DM, Fagan AM. (2008). Abnormal CSF Amyloid-beta 42 Levels Link HIV-Associated Cognitive Disease and Alzheimer's Disease. 15th Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts, February 3-6, 2008. | | Harrison TB, Schweinsburg BC, Jacobus J, Theilmann RJ, Taylor MJ, Woods SP, Gongvatana A, Franklin DR, Ellis RJ, Letendre SL, Heaton R, Frank L, Grant I, Jernigan T. Abnormal white matter signal and lower CD4 nadir independently predict lower white matter fractional anisotropy in HIV-infected individuals. 36th Annual International Neuropsychological Society Meeting, Waikoloa, Hawaii, 02-06-2008. | | Taylor MJ, Jernigan TL, Schweinsburg BC, Woods SP, Abramson IS, Clifford DB, Collier AC, Ellis RJ, Gamst AC, Gelman BB, Heaton RK, Letendre SL, Marcotte TD, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I. Frontal white matter and gray matter integrity measured by proton magnetic resonance spectroscopy predict different neuropsychological functions in HIV-infected individuals. uropsychological Society Meeting, Waikoloa, Hawaii, 02-06-2008. | | Ellis R, Marquie-Beck J, Delaney P, Alexander T, Clifford D, McArthur J, Simpson D, Ake C, Collier A, Gelman B, and the CHARTER Group. HIV protease inhibitors and risk of peripheral neuropathy. 15th Conference on Retroviruses and Opportunistic Infections, Boston, Mass, 02-05-2008. | | Jacobus J, Schweinsburg BC, Theilmann RJ, Taylor MJ, Woods SP, Harrison TB, Gongvatana A, Franklin DR, Letendre SL, Ellis RJ, Heaton RK, Frank LR, Grant I, Jernigan TL. Neurocognitive performance predicts altered white matter fractional anisotropy in HIV-infected individuals. 36th Annual International Neuropsychological Society Meeting, Waikoloa, Hawaii, 02-06-2008. | | Pillai S, Pasutti W, McCutchan JA, Marra C, Clifford D, Gelman B, Simpson D, McArthur J, Grant I, Wong J. Validation of a V3-based genetic biomarker of HIV-1 neurovirulence. 15th Conference on Retroviruses and Opportunistic Infections, Boston, Mass, 02-03-2008. | | Jernigan TL, Archibald SL, Taylor MJ, Woods SP, Abramson I, Clifford D, Collier A, Ellis RJ, Gamst AC, Gelman BB, Heaton R, Letendre S, Marcotte T, Marra C, McArthur JC, McCutchen JA, Morgello S, Simpson D, Grant I. (2008). White matter damage and cortical volume loss affect different cognitive and motor functions in HIV-infected individuals. Journal of the International Neuropsychological Society, 14(Suppl. 1), 243. | | Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Franklin DR, Jernigan TL, Frank LR, Grant I. White matter tract injury and cognitive impairment in HIV-infected individuals. 36th Annual International Neuropsychological Society Meeting, Waikoloa, Hawaii, 02-06-2008. | | Henninger DE, Franklin D, Heaton RK, Morgello S, Rivera-Mindt M, and the CHARTER Group. A model of HIV infection, aging, neuropsychological and vocational functioning, and employment. nference of the American Academy of Clinical Neuropsychology, Denver, CO, 06-2007. | | | Biswas B, Collier AC, Gelman BB, McArthur JC, Morgello S, McCutchan JA, Clifford DB, and the CHARTER Group. (2007). Associations between adherence and neurocognitive performance among HIV-infected individuals: is near perfect adherence necessary? 2nd International Conference on HIV Treatment Adherence, Session 306. | | Jernigan T, Letendre S, Archibald S, Clifford D, Collier A, Gelman B, MacArthur J. McCutchan J. Morgello S, Simpson D, Grant I, Ellis R, and the CHARTER Group. Chemokines in CSF are associated with white matter and cortical gray matter volumes in HIV-infected individuals. nnual Conference on Retroviruses and Opportunistic Infections, Los Angeles, CA, 02-25-2007. | | Letendre S, Marquie-Beck J, Clifford D, Collier A, Gelman B,McArthur J, McCutchan J, Simpson D, Grant I, Ellis R, and the CHARTER Group. Clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system. ruses and Opportunistic Infections, Los Angeles, CA, 02-25-2007. | | Best BM, Letendre S, Rossi S, Clifford D, Collier A, Gelman B, McArthur J, McCutchan J, Morgello S, Ellis R. Low exposure to Paroxetine and Sertraline, but not to Citalopram, Escitalopram and Fluoxetine in HIV-infected patients. al Conference on Retroviruses and Opportunistic Infections, Los Angeles, CA, 02-25-2007. | | Letendre S, McClernon D, Benjamin R, Clifford D, Collier A, Gelman B, McArthurJ, McCutchan J, Morgello S, Ellis R, and the CHARTER Group. Presence of HIV RNA in cerebrospinal fluid that is undetectable with the ultrasensitive assay. al Conference on Retroviruses and Opportunistic Infections, Los Angeles, CA, 02-25-2007. | | | Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Ake C, Clifford D, McArthur JC, Simpson D, Collier A, Gelman BB, McCutchan JA, Morgello S, Grant I, and the CHARTER Group. (2007). Use of protease inhibitors does not independently contribute to distal polyneuropathy in HIV infection. 8th International Symposium on NeuroVirology. | | Henninger DE, Byrd D, Franklin D, Heaton RK, Morgello S, Rivera-Mindt M, and the CHARTER Group. Aging and HIV infection: the relationship between neuropsychological and vocational functioning. 9th Scientific Meeting of the Gerontological Society of America, 2006. | | Wong J, Pillai S, Ellis R, Clifford D, Collier A, Gelman B, McArthur J, McCutchan J, Morgello S, Grant I, and the CHARTER Group. Discordance of genotypic resistance between CSF and plasma virus in a multicenter observational cohort. 13th Annual Conference on Retroviruses and Opportunistic Infections, Denver, CO, 02-05-2006. | | Best BM, Letendre S, Patel P, Clifford D, Collier A, Gelman B, McArthur J, McCutchan J, Simpson D, Capparelli E. Low Atazanavir concentrations in cerebrospinal fluid. 13th Annual Conference on Retroviruses and Opportunistic Infections, Denver, CO, 02-05-2006. |
|